Rare Cancers Australia has released its 2025 Election Priorities, which advocate for consistent access to specialised expertise, treatments, and genomic medicines.
-
Latest News Rare Cancers Australia says election is the chance to end the ‘cancer lottery’ February 12, 2025
-
Latest News Immunoglobulin sales drives a strong first half for CSL but lower immunisation rates hit Seqirus February 12, 2025CEO and managing director Dr Paul McKenzie said, “CSL delivered a solid result for the first half of the 2025 financial year led by CSL Behring. Strong demand for many of our market-leading therapies has translated into sales growth, particularly in our core Ig franchise. We continue to advance key initiatives to improve gross margin, which is tracking according to our plans."
-
Latest News AdvanCell extends collaboration with Lilly to advance novel targeted alpha therapies February 11, 2025Australian clinical-stage radiopharmaceutical company AdvanCell has announced an expansion of its strategic collaboration with Eli Lilly to research and develop innovative cancer treatments.
-
Latest News Specialised Therapeutics announces Thai approval of breast cancer therapy February 12, 2025“We are extremely excited about the new journey we are undertaking in Thailand,” said Specialised Therapeutics CEO Carlo Montagner.
-
Latest News Merck adds experienced industry executive to leadership team February 11, 2025Josie Downey, the managing director of Merck Healthcare Australia and New Zealand, has welcomed Jo Galea to the company's leadership team.
-
Latest News Proponents of meaningful reform might consider pharmacy prescribing as a case study February 11, 2025Stakeholders arguing for meaningful reform in other parts of the PBS should take heart. The adoption of pharmacy prescribing shows that the system can compromise on longstanding articles of faith when the case for change is effectively made.
-
Latest News New Omico podcast aims to help people navigate precision oncology and genomic innovation February 11, 2025Not-for-profit genomics company Omico is launching a new podcast, Cancer Meets its Match, designed to assist people diagnosed with difficult cancers, along with their families and carers.
-
Latest News PSA welcomes women’s health initiatives as significant step forward in improving access February 10, 2025PSA national president Associate Professor Fei Sim said, "This announcement will take these programs one step further, allowing pharmacists to initiate hormonal contraceptives and supply medications under the PBS for the first time."
-
Latest News First-time policy breakthrough with pharmacies to write PBS prescriptions February 9, 2025The prescriptions will be subsidised through the PBS. This means that community pharmacies will, for the first time, be able to prescribe and dispense PBS-subsidised medicines.
-
Latest News Historical change on pharmacy prescribing could be a sign of more to come February 10, 2025Allowing pharmacies to prescribe and dispense PBS-subsidised medicines is undeniably one of the most significant reforms in the program's eight-decade history.
-
Latest News 'Unfortunately, there remain significant gaps in knowledge among healthcare professionals when it comes to menopause' February 10, 2025“It is enormously encouraging to see a key recommendation from the Senate inquiry into menopause being put into action, with these modern menopausal hormone therapies becoming readily accessible for all Australian women,” said Geoff Blundell, the managing director of Besins Healthcare Australia.
-
Latest News Victorian official appointed to HTA Review implementation advisory group February 10, 2025A senior Victorian government official has been appointed as the jurisdictional representative on the Health Technology Assessment Review Implementation Advisory Group.
-
Latest News Sigma upgrades guidance as it prepares for Chemist Warehouse merger February 10, 2025"The upgrade follows improved operational performance, including the strong execution of the new Chemist Warehouse supply contract that commenced on 1 July 2024, demonstrating our ability to efficiently absorb volume growth," said the company.
-
Latest News 'In an optimal, equitable system, access to evidence-based, cost-effective genomics-guided medicines would be provided to all' February 7, 2025Cancer Australia has used its newly released National Framework for Genomics in Cancer Control to support changes to streamline timely and equitable access to genomics-informed treatments.
-
Podcast The 'Dispatched' week in review podcast - 7 February February 6, 2025Genetics and genomics are the focus of this week's episode. It was a significant week with the release of one organisation's pre-budget submission and a new national framework. Not everyone is happy, but is the criticism fair?
-
Latest News GSK out to an early lead in Rare Cancers Australia Kosi Challenge 'Pharma Cup' February 7, 2025With five weeks until the annual challenge, the company has raised over $13,000, leading AstraZeneca and Alexion with $10,000 and Pfizer with over $6,000. Pharma Cup teams have raised close to $55,000 so far.
-
Latest News 'One believes things because one has been conditioned to believe them' February 6, 2025Imagine that a program like the aged pension worked by determining a limited, pre-set selection of items recipients could purchase. Imagine that a group of so-called experts determined that list based primarily on the state's economic interests and limited consultation with seniors. The community would be understandably outraged, so why is it acceptable in healthcare?
-
Latest News RFK Jr on the cusp of securing his nomination to lead the US health department February 6, 2025Betting websites put his chances of securing his appointment at over 95 per cent, with some wavering Republican Senators now indicating their support for Mr Kennedy.
-
Australian Biotech Sanofi Ventures joins investors backing Australian radionuclide company February 6, 2025This funding round was co-led by SV Health Investors, Sanofi Ventures, Abingworth, and SymBiosis. Additional support came from existing investor Morningside, alongside new investors Tenmile, Brandon Capital, and others.
Australian Biotech
-
AdvanCell extends collaboration with Lilly to advance novel targeted alpha therapies
February 11, 2025 -
Sanofi Ventures joins investors backing Australian radionuclide company
February 6, 2025 -
QBiotics strengthens medical leadership with two senior appointments
January 28, 2025 -
IDT updates investors, expecting a significant spike in revenue
January 28, 2025 -
CEPI backing for Vaxxas to advance needle-free thermostable mRNA vaccines
January 23, 2025
Other Health
-
BTC announced new partnership agreement with Corcym
December 9, 2024 -
NSW government backs down on health tax in new agreement with health funds
December 2, 2024 -
Ramsay Health Care and Bupa join forces to develop our next generation of nurses
November 19, 2024 -
Medibank expands four-day work week trial to 500 employees
October 9, 2024 -
Artrya submits application for Salix to the US FDA
September 30, 2024
Latest Video
New Stories
-
Immunoglobulin sales drives a strong first half for CSL but lower immunisation rates hit Seqirus
February 12, 2025 - - Latest News -
Rare Cancers Australia says election is the chance to end the ‘cancer lottery’
February 12, 2025 - - Latest News -
Specialised Therapeutics announces Thai approval of breast cancer therapy
February 12, 2025 - - Latest News -
Merck adds experienced industry executive to leadership team
February 11, 2025 - - Latest News -
Sandoz summit promotes reform to boost the use of biosimilars
February 11, 2025 - - Latest News -
AdvanCell extends collaboration with Lilly to advance novel targeted alpha therapies
February 11, 2025 - - Latest News -
Immunoglobulin sales drives a strong first half for CSL but lower immunisation rates hit Seqirus
February 11, 2025 - - Latest News